Laura Blackburn

Name:	Laura Blackburn
Affiliation:	Cambridge Research Institute, Cancer Research UK
E-mail:	(only provided to users who are logged into talks.cam)
Last login:	1 Feb 2021, 3:51 p.m.

Public lists managed by Laura Blackburn

Talks given by Laura Blackburn

Obviously this only lists talks that are listed through talks.cam. Furthermore, this facility only works if the speaker's e-mail was specified in a talk. Most talks have not done this.

Talks organised by Laura Blackburn

This list is based on what was entered into the 'organiser' field in a talk. It may not mean that Laura Blackburn actually organised the talk, they may have been responsible only for entering the talk into the talks.cam system.

• Senescence, cell death and apoptosis
• Oncogenes and tumour suppressors (signalling and pathways)
• Transcription
• Development and the cell cycle
• Genetic instability - observation and concepts
• Overview of cancer theoretical framework
• Tumour natural history, structure and nomenclature (lecture/demonstration)
• Cellular hierarchies in normal and malignant epithelial tissue
• Noninvasive cancer genomics
• Epigenetics and microRNA
• Epidemiology
• MRI and MRS in cancer research and treatment
• Radiotherapy
• Metabolism, oxygen and cancer
• Drug discovery
• Therapeutics and clinical trials
• Signal transduction
• **Postponed to 22 May** Drug discovery
• Centrosome changes in cancer – causes and consequences
• **Postponed to 19 June** Epidemiology
• In vivo models
• Genomic technologies
• Solid vs. non-solid tumours
• Computational biology
• Transcriptional regulation and techniques
• Circulating DNA and diagnostics
• Metastasis
• Tumour metabolism
• Stem cells and cancer
• Introduction to cancer in Cambridge (BP) followed by Cell cycle and checkpoints (AP)
• Development
• Computational biology
• Epigenetic cancer conspirators: DNA methylation, non-coding RNA and chromatin loops
• Proteinases and Cancer
• Stem cells and cancer
• Estrogen receptor and its role in transcription and breast cancer
• Microtubules: boring polymers or the Achilles heel of cancer?
• Multiparametric MRI of the vasculature: applications to therapy monitoring of gliomas
• **Talk postponed** Introduction to statistics
• A systems view of the cancer cell: from missing genetic variability to combination therapy
• Clinical lectures on prostate, bladder, renal and testis cancer
• Functional breast cancer genomics: from basic biology to clinical application
• Developing imaging approaches for novel cancer therapies
• Imaging tumour responses to treatment
• MRI and MRS in cancer research and cancer treatment
• *CANCELLED* Wnt signalling, Lgr5 stem cells and cancer
• Cancer Therapeutics
• Barrett's oesophagus as a model for early cancer detection/treatment
• Title to be confirmed
• Genomic Imprinting and Cancer
• Genes into Geometry: Imaging for mouse phenotyping
• Signal transduction and membrane trafficking
• Title to be confirmed
• Control of DNA Replication
• Systems approaches to understanding transcriptional regulation
• Tumour suppressors mechanisms and cellular senescence
• Oncogenes and Tumour Suppressors 1 & 2
• New approaches to the clinical management of cervical cancer
• Talk Cancelled
• Radiotherapy in the management of cancer
• Stem cell fate
• Why computational biology is useful in the cancer world
• Cell Signalling
• Biochemical network reconstruction from data
• Adoptive T Cell Therapy of Cancer
• Towards a transcriptional taxonomy of in vitro stem cell preparations
• Prospective translational research in clinical trials
• Genome scans in breast and prostate cancer - what have we learned & where next?
• Germ Cell Tumours (GCTs) of Young People: Clinical and Biological Approaches
• Is brain cancer a stem cell disease?
• Translational imaging studies in ovarian cancer
• The Executable Pathway to Biological Networks
• Using genetics to personalize melanoma therapy
• Common germline variation and colorectal cancer
• Inherited susceptibility to cancer
• The Code Underlying Tissue-Regulated Splicing
• Assessing responses to cancer therapy using molecular imaging magnetic resonance methods
• OPCML in Tumour Gene Therapy in Ovarian Cancer
• Stem cells and cancer (epithelial cancers)
• Preservation of fertility in patients with cancer
• Analysis of early events after DNA damage in living cells; the HP1 paradigm
• What comes after cancer stem cells?
• Outreach chemotherapy programme
• Intestinal cancer models and stem cell biology
• Radiation-induced bowel damage: let's put right what is wrong
• Genetic association studies to find common disease susceptibility alleles
• The role of cyclin-kinase inhibitors in the development of cancer
• Clinical potential of functional ion channel expression in cancer
• Sarcomas and the insulin-like growth factor pathway
• The evidence for lifestyle after cancer to reduce relapse and survival
• Title to be confirmed
• Tumour suppressors 1 and 2
• The role of developmental biology in cancer research
• Colorectal neoplasia: what we know and don't know about genes and environment
• The Editorial Process Demystified
• The West Anglia CLRN, TCRNs and the Coordinated System for gaining NHS Permission – How is it all going to work?
• Mechanisms of DNA replication
• The role of Fam38 in integrin activation and lung cancer
• High-throughput cancer cell line screening: a tool for discovery
• Title to be confirmed
• Title to be confirmed
• Early phase clinical trials in Cambridge
• Special seminar: Analysing the dynamic glycome
• TBC
• Using Bayesian analysis in randomised phase II clinical trials to determine the worth of proceeding to phase III
• 'Mechanisms of tamoxifen action and resistance' and 'Cambridge Oncology - Past, Present & Future: A tour from the 18th to 21st Century'
• Taming Glioblastoma -Targeting Angiogenesis (CRI Special Seminar)
• Targeted therapries in cancer
• Trials and Tribulations in the Management of Head and Neck Cancer
• TBC
• TBC
• Targeting Hyperactive Ras and Uncovering Mechanisms of Therapeutic Resistance in Genetically Engineered Mice
• Chromosome translocations and gene fusions in breast cancer and Improving outcomes in melanoma: a fresh look
• Title to be confirmed
• Breast Cancer Heterogeneity and the Cancer Stem Cell Hypothesis
• Title to be confirmed
• 'Monitoring anticancer drug uptake by magnetic imaging and spectroscopy' and 'Breast cancer heterogeneity- a clinical challenge'
• Title to be confirmed
• CANCELLED: Inherited susceptibility to cancer
• Experimental manipulation of the epidermis to study normal and cancer stem cells and The GIST of GISTS (Gastrointestinal Stromal tumours)
• Title to be confirmed
• Imaging biology in the cancer patient (K. Brindle)
• Ubiquitin / proteasome mediated protein degradation
• "Computational biology and cancer: the CRI perspective" and "Lung Cancer: A New Strategy"
• Acute Myeloid Leukaemia: Molecular Pathogenesis, Prognostication and Targeted therapy (Brian Huntly)
• Beyond VEGF: vascular signaling targets for therapeutic manipulation
• Tumour Suppressors 1 and 2
• Searching for and confirming common breast cancer risk alleles (Dunning) Update on Diet and Breast Cancer (Bingham)
• Tumour suppressor mechanisms and cellular senescence
• Progress in prostate cancer and the androgen receptor
• Title to be confirmed
• "High throughput mapping of cis-regulatory DNA elements: From genomic arrays to functional biology" (George Follows) & "Rapid evolutionary turnover of transcription factor binding" (Duncan Odom)